Regulatory Updates
Sep 27, 2026•1 min read
FDA Discontinues Nitrofurantoin Tablet (ANDA 084085) by Whiteworth Town PLsn
The FDA has listed the oral Nitrofurantoin 100 mg tablet (product 002) from Whiteworth Town PLsn as discontinued under ANDA 084085.
Regulatory Updates
Sep 27, 2026•1 min read
FDA Discontinues PROCAN SR (ANDA086468) – Oral Extended-Release Tablet
FDA records indicate that PROCAN SR, an oral extended‑release tablet containing 250 mg procaineamide hydrochloride, has been discontinued. Sponsor Parke Davis filed multiple labeling submissions.
Regulatory Updates
Sep 25, 2026•1 min read
FDA Discontinues Testosterone Enanthate Injectable Products (ANDA083667)
The FDA has discontinued two injectable testosterone enanthate products from Watson Labs, listed under ANDA083667.
Regulatory Updates
Sep 22, 2026•1 min read
FDA Discontinues Chlordiazepoxide Hydrochloride ANDA084700
The FDA has listed the ANDA084700 application for Chlordiazepoxide Hydrochloride 10 mg oral capsules as discontinued. Sponsor Roxane filed the original ANDA in 1976.
Regulatory Updates
Sep 16, 2026•1 min read
FDA Discontinues HALOPERIDOL Injectable (ANDA070802)
The FDA has marked the HALOPERIDOL injectable (product 001) as discontinued under application ANDA070802 submitted by Smith & Nephew.
Regulatory Updates
Sep 16, 2026•1 min read
FDA Discontinues Wellcovorin Injection (ANDA089465)
The FDA records show that the injectable product Wellcovorin, containing Leucovorin Calcium (50 mg per vial), has been marked as discontinued under ANDA089465.
Regulatory Updates
Sep 10, 2026•1 min read
FDA Discontinues Oral Prednisolone Tablet (ANDA083675)
The FDA has listed the oral prednisolone 5 mg tablet (product 001) from sponsor Bundy as discontinued under ANDA083675.
Regulatory Updates
Sep 8, 2026•1 min read
FDA Discontinues Oral Solution PAMELOR (Nortriptyline Hydrochloride) – NDA 018012
The FDA records show PAMELOR oral solution (nortriptyline hydrochloride) is discontinued, with a history of labeling and manufacturing submissions from 1977 to 2014.
Regulatory Updates
Aug 30, 2026•1 min read
FDA Discontinues Isoniazid Tablet (ANDA083060)
FDA lists the oral Isoniazid 100 mg tablet from sponsor PERRIGO (ANDA083060) as discontinued, with no reference drug status.